A Preview Of Regenxbio's Earnings
Portfolio Pulse from Benzinga Insights
Regenxbio (NASDAQ:RGNX) is scheduled to release its quarterly earnings report on February 27, 2024, with analysts expecting an EPS of $-1.27. The company's past earnings performance shows a mix of beats and misses, with the share price reacting accordingly. Shares are currently trading at $17.41, down 17.17% over the last year. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.
February 26, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Regenxbio is expected to announce its quarterly earnings with an anticipated EPS of $-1.27. Historical performance shows variability in beating EPS estimates and its impact on stock price. Currently, shares are down 17.17% over the last year.
Given Regenxbio's mixed history of beating earnings estimates and the subsequent stock price reactions, the upcoming earnings report and especially the guidance for future quarters will be crucial for investors. The current downward trend in stock price over the past year indicates investor sentiment may be low, making this earnings report particularly significant for short-term price movement. However, without specific news indicating a significant beat or miss, the score remains neutral.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100